The antibody-combining site is formed by the interaction of the variable regions of the H and L chains; hence, replacement of either V changes the specificity of an antibody ([@bib8]; [@bib22]; [@bib31]). A characteristic feature of anti-DNA antibodies is that DNA contact is mediated primarily through the positively charged amino acid residue Arg in H-chain complementarity determining regions (CDRs; [@bib11]; [@bib21], [@bib23]; [@bib29]). Hence, these Arg-containing H chains bind DNA regardless of most L chains ([@bib9]). However, several L chains in mouse can modify or veto DNA binding when paired with anti-DNA H chains ([@bib17]). These L chains are called editors and share functionally consequential structural characteristics such as a low isoelectric point (pI) and negatively charged aspartate residues (Asp) in CDRs ([@bib17]).

Editor L chains were originally discovered in anti-DNA H-chain transgenic models ([@bib8]; [@bib22]). The majority of peripheral B cells bearing anti-DNA transgenic H chains were paired with editor L chains, indicating that only those B cells that edited their receptors were allowed to migrate to the periphery. Editing of anti-DNA receptors also influences the endogenous mouse repertoire; antibodies which use editor L chains have characteristics of lupus anti-DNA antibodies---namely, a high frequency of H chains with Args in H3 (H3-Arg) ([@bib12]).

Here, we studied the human antibody repertoire to determine whether it contains L chains similar to the mouse editors, whether such human L chains silence or modify anti-DNA activity, and whether antibodies that express these L chains have a high frequency of H chains with H3 Arg relative to the total human antibody repertoire. We used mouse editor L chain sequences as a guideline for identifying human editor L chains. We focused on the prominent sequence characteristics of editors---namely, the number and location of Asps in L-chain CDRs. Using this criterion, we identified several potential human editor L chains. We tested the ability of the human editors to modify DNA binding by H chains derived from monoclonal anti-DNA antibodies and found that they can silence anti-DNA H chains from both humans and mice. Because the human H3s are generated by mechanisms similar to those in mice, we reasoned that the human endogenous H-chain repertoire might also include H3-Args. If editing of anti-DNAs is a tolerance mechanism which operates in humans, then we would expect that these Arg-containing H chains are preferentially expressed with human editor light chains. This is indeed the case. This finding provides an understanding of how tolerance to DNA is maintained and, importantly, how the B cell repertoire is shaped in humans.

RESULTS
=======

Human anti-DNA L chain editors
------------------------------

Human light chains similar to mouse editors were identified using the Ig Blast database ([Table 1](#tbl1){ref-type="table"}). Most, but not all, of these human L chains have Asps in CDRs ([Table 1](#tbl1){ref-type="table"}) and a low pI ([Fig. 1](#fig1){ref-type="fig"}). The location of Asps is the same in some of the mouse and human editor L chains, such as mouse Vκ38c and VλX and their respective human homologues VκO8/O18 and Vλ5-1 ([Table 1](#tbl1){ref-type="table"}). Our results are consistent with the observation that Asps in L chain CDR regions are particularly important for editing of anti-DNA H chains ([@bib23]; [@bib10]). The importance of CDR Asps for editing was originally shown in studies of the mouse L chain editors ([@bib8]; [@bib22]; [@bib17]). Substitution of any of the L chain CDR1 (L1) Asp by alanine in the L chain of an anti-DNA antibody resulted in increased DNA binding ([@bib11]). The ability of Asp in L2 to interact with Arg in a H3 was revealed in the crystal structure of an anti--poly-Q antibody ([@bib19]).

###### 

Protein sequences of mouse editor, human potential editor and human non-editor light chains analyzed in this study

  Name                                      FW1                       CDR1                                          FW2               CDR2                         FW3                                 CDR3
  ----------------------------------------- ------------------------- --------------------------------------------- ----------------- ---------------------------- ----------------------------------- -----------------------
  **Mouse editor light chains**                                                                                                                                                                        
  VκBt20                                    STTVTQSPASLSMAIGEKVTIRC   ITST[D]{.ul}I[DD]{.ul}\-\-\-\-\--[D]{.ul}MN   WYQQKPGEPPKLLIS   EGNTLRP\-\-\-\--             GVPSRFSSSGYGTDFVFTIENMLSEDVADYYCL   QS[D]{.ul}NLP\-\-\--
  VκBw20                                    ETTVTQSPASLSVATGEKVTIRC   ITST[D]{.ul}I[DD]{.ul}\-\-\-\-\--[D]{.ul}MN   WYQQKPGEPPKLLIS   EGNTLRP\-\-\-\--             GVPSRFSSSGYGTDFVFTIENTLSEDVADYYCL   QS[D]{.ul}NMP\-\-\--
  Vκ21-4                                    DIVLTQSPASLAVSLGQRATISC   KASQS-V[D]{.ul}YD-G[D]{.ul}SYMN               WYQQKPGQPPKLLIY   AASNLES\-\-\-\--             GIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQ   QSNE[D]{.ul}P\-\-\--
  Vκ12-46                                   DIQMTQSPASLSVSVGETVTITC   RASENIYS\-\-\-\-\--NLA                        WYQQKQGKSPQLLVY   AATNLA[D]{.ul}\-\-\-\--      GVPSRFSGSGSGTQYSLKINSLQSEDFGSYYCQ   HFWGTP\-\-\--
  VκGj38c                                   DIQMTQSPSSLSASLGGKVTITC   KASQ[D]{.ul}INK\-\-\-\-\--YIA                 WYQHKPGKGPRLLIH   YTSTLQP\-\-\-\--             GIPSRFSGSGSGRDYSFSISNLEPEDIATYYCL   QY[D]{.ul}NLL\-\-\--
  VλX                                       QLVLTQSS-SASFSLGASAKLTC   TLSSQHST\-\-\-\--YTIE                         WYQQQPLKPPKYVME   LKK[D]{.ul}GSH-STG[D]{.ul}   GIPDRFSGSSSGADRYLSISNIQPEDEAIYIC    GVG[D]{.ul}TIKEQFV
  **Human potential editor light chains**                                                                                                                                                              
  VκO8/O18                                  DIQMTQSPSSLSASVGDRVTITC   QASQ[D]{.ul}ISN\-\-\-\-\--YLN                 WYQQKPGKAPKLLIY   [D]{.ul}ASNLET\-\-\-\--      GVPSRFSGSGSGTDFTFTISSLQPEDIATYYC    QQY[D]{.ul}NLP\-\-\--
  VκL11                                     AIQMTQSPSSLSASVGDRVTITC   RASQGIRN\-\-\-\-\--[D]{.ul}LG                 WYQQKPGKAPKLLIY   AASSLQS\-\-\-\--             GVPSRFSGSGSGTDFTLTISSLQPEDFATYYC    LQ[D]{.ul}YNYP\-\-\--
  VκO2/O12                                  DIQMTQSPSSLSASVGDRVTITC   RASQSISS\-\-\-\-\--YLN                        WYQQKPGKAPKLLIY   AASSLQS\-\-\-\--             GVPSRFSGSGSGTDFTLTISSLQPEDFATYYC    QQSYSTP\-\-\--
  Vλ5-1                                     LPVLTQPPSASALLGASIKLTCT   LSSEHST\-\-\-\-\--YTIE                        WYQQRPGRSPQYIMK   VKS[D]{.ul}GSH-SKG[D]{.ul}   GIPDRFMGSSSGADRYLTFSNLQSDDEAEYHC    GESHTI[D]{.ul}GQVG
  Vλ5-2                                     QPVLTQPPSASASLGASVTLTCT   LSSGYSN\-\-\-\-\--YKV[D]{.ul}                 WYQQRPGKGPRFVMR   VGTGGIVGSKG[D]{.ul}          GIPDRFSVLGSGLNRYLTIKNIQEEDESDYHC    GA[D]{.ul}HGSGSNFV
  Vλ5-4                                     QPVLTQSSSASASLGSSVKLTCT   LSSGHSS\-\-\-\-\--YIIA                        WHQQQPGKAPRYLMK   LEGSGSY-NKGS                 GVPDRFSGSSSGADRYLTISNLQFEDEADYYC    ETW[D]{.ul}SNT\-\-\--
  Vλ5-6                                     QLVLTQSPSASASLGASVKLTCT   LSSGHSS\-\-\-\-\--YAIA                        WHQQQPEKGPRYLMK   LNS[D]{.ul}GSH-SKG[D]{.ul}   GIPDRFSGSSSGAERYLTISSLQSEDEADYYC    QTWGTG\-\-\-\--
  **Human non-editor light chains**                                                                                                                                                                    
  VκA2                                      DIVMTQTPLSLSVTPGQPASISC   KSSQSLLHS[D]{.ul}-GKTYLY                      WYLQKPGQPPQLLIY   EVSNRFS\-\-\-\--             GVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC    MQSIQLP\-\-\--
  VκA17                                     DVVMTQSPLSLPVTLGQPASISC   RSSQSLVYS[D]{.ul}-GNTYLN                      WFQQRPGQSPRRLIY   KVSNR[D]{.ul}S\-\-\-\--      GVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC    MQGTHWP\-\-\--
  VκA19                                     DIVMTQSPLSLPVTPGEPASISC   RSSQSLLHSN-GYNYLD                             WYLQKPGQSPQLLIY   LGSNRAS\-\-\-\--             GVPDRFSGSGSGTDFTLKISRVEAEDVGVYYC    MQALQTP\-\-\--
  VκA20                                     DIQMTQSPSSLSASVGDRVTITC   RASQGISN\-\-\-\-\--YLA                        WYQQKPGKVPKLLIY   AASTLQS\-\-\-\--             GVPSRFSGSGSGTDFTLTISSLQPEDVATYYC    QKYNSAP\-\-\--
  VκA23                                     DIVMTQTPLSSPVTLGQPASISC   RSSQSLVHS[D]{.ul}-GNTYLS                      WLQQRPGQPPRLLIY   KISNRFS\-\-\-\--             GVPDRFSGSGAGTDFTLKISRVEAEDVGVYYC    MQATQFP\-\-\--
  VκA26                                     EIVLTQSPDFQSVTPKEKVTITC   RASQSIGSS\-\-\-\-\--LH                        WYQQKPDQSPKLLIK   YASQSFS\-\-\-\--             GVPSRFSGSGSGTDFTLTINSLEAEDAATYYC    HQSSSLP\-\-\--
  VκA27                                     EIVLTQSPGTLSLSPGERATLSC   RASQSVSSS\-\-\-\--YLA                         WYQQKPGQAPRLLIY   GASSRAT\-\-\-\--             GIPDRFSGSGSGTDFTLTISRLEPEDFAVYYC    QQYGSSP\-\-\--
  VκA30                                     DIQMTQSPSSLSASVGDRVTITC   RASQGIRN\-\-\-\-\--[D]{.ul}LG                 WYQQKPGKAPKRLIY   AASSLQS\-\-\-\--             GVPSRFSGSGSGTEFTLTISSLQPEDFATYYC    LQHNSYP\-\-\--
  VκB3                                      DIVMTQSPDSLAVSLGERATINC   KSSQSVLYSSNNKNYLA                             WYQQKPGQPPKLLIY   WASTRES\-\-\-\--             GVPDRFSGSGSGTDFTLTISSLQAEDVAVYYC    QQYYSTP\-\-\--
  VκL1                                      DIQMTQSPSSLSASVGDRVTITC   RASQGISN\-\-\-\-\--YLA                        WFQQKPGKAPKSLIY   AASSLQS\-\-\-\--             GVPSRFSGSGSGTDFTLTISSLQPEDFATYYC    QQYNSYP\-\-\--
  VκL2                                      EIVMTQSPATLSVSPGERATLSC   RASQSVSSN\-\-\-\-\--LA                        WYQQKPGQAPRLLIY   GASTRAT\-\-\-\--             GIPARFSGSGSGTEFTLTISSLQSEDFAVYYC    QQYNNWP\-\-\--
  VκL5                                      DIQMTQSPSSVSASVGDRVTITC   RASQGISS\-\-\-\-\--WLA                        WYQQKPGKAPKLLIY   AASSLQS\-\-\-\--             GVPSRFSGSGSGTDFTLTISSLQPEDFATYYC    QQANSFP\-\-\--
  VκL6                                      EIVLTQSPATLSLSPGERATLSC   RASQSVSS\-\-\-\-\--YLA                        WYQQKPGQAPRLLIY   DASNRAT\-\-\-\--             GIPARFSGSGSGTDFTLTISSLEPEDFAVYYC    QQRSNWP\-\-\--
  VκL8                                      DIQLTQSPSFLSASVGDRVTITC   RASQGISS\-\-\-\-\--YLA                        WYQQKPGKAPKLLIY   AASTLQS\-\-\-\--             GVPSRFSGSGSGTEFTLTISSLQPEDFATYYC    QQLNSYP\-\-\--
  VκL9                                      AIRMTQSPSSFSASTGDRVTITC   RASQGISS\-\-\-\-\--YLA                        WYQQKPGKAPKLLIY   AASTLQS\-\-\-\--             GVPSRFSGSGSGTEFTLTISSLQPEDFATYYC    QQLNSYP\-\-\--
  VκL12a                                    DIQMTQSPSTLSASVGDRVTITC   RASQSISS\-\-\-\-\--WLA                        WYQQKPGKAPKLLIY   KASSLES\-\-\-\--             GVPSRFSGSGSGTEFTLTISSLQPDDFATYYC    QQYNSYSP\-\--
  VκL4/18a                                  AIQLTQSPSSLSASVGDRVTITC   RASQGISS\-\-\-\-\--ALA                        WYQQKPGKAPKLLIY   DASSLES\-\-\-\--             GVPSRFSGSGSGTDFTLTISSLQPEDFATYYC    QQFNSYP\-\-\--
  L23                                       AIRMTQSPFSLSASVGDRVTITC   WASQGISS\-\-\-\-\--YLA                        WYQQKPAKAPKLFIY   YASSLQS\-\-\-\--             GVPSRFSGSGSGTDYTLTISSLQPEDFATYYC    QQYYSTP\-\-\--
  L24                                       VIWMTQSPSLLSASTGDRVTISC   RMSQGISS\-\-\-\-\--YLA                        WYQQKPGKAPELLIY   AASTLQS\-\-\-\--             GVPSRFSGSGSGTDFTLTISCLQSEDFATYYC    QQYYSFP\-\-\--

Framework (FW) and CDR regions are identified according to Kabat definition, Asp residues (D) are underlined in CDR regions. Four Ds in CDRs are not underlined: (1) in Vk21-4 CDR1, (2) in VkA19 CDR1, (3) inVkL6 CDR2, and (4) in VkL4/18a CDR2. Not all human L chains listed in the table, but only those that were found in our survey.

![**The pI of CDR regions of mouse and human L chains**. Mouse and human L chains are plotted in order of increasing CDR pI. CDRs are identified according to the Kabat definition. Mouse editor and human putative editor L chain CDR pI values are shown in solid blocks and these L chains are labeled on the X axis. The pI values for the remaining L chains are shown as open data points to place the editors in context within the full set of L chains in mouse and in human.](JEM_20122340_Fig1){#fig1}

Asp in L chain CDRs is neither necessary nor sufficient for editing; we found human L chain editors without Asps that can edit, demonstrating that editing is not restricted to the presence of Asps. For example, the human L chain, VκO2/O12, homologous to mouse editor L-chain Vκ12-46, does not have CDR Asps but does veto DNA-binding and antinuclear antibody (ANA) activity of anti-DNA H chains ([Table 1](#tbl1){ref-type="table"} and [Fig. 2](#fig2){ref-type="fig"}). Conversely, a homologue of the mouse editor VλX, human Vλ5-6, has two Asps in L2 but does not veto DNA or ANA activity of either mouse or human H chains with H3-Args ([Table 1](#tbl1){ref-type="table"} and [Fig. 2](#fig2){ref-type="fig"}). Human Vλ5-6 and mouse VλX have a similar VL sequence, including the two Asps in L2 (also found in Vλ5-1), but are dissimilar in L3. Both VλX and its closest human homologue Vλ5-1 have long L3s that contain Asp in site 96, whereas Vλ5-6 has a short L3 and no L3 Asp. As shown for VλX junctional variants, L3 is of paramount importance for editing ([@bib24]).

![**dsDNA binding and ANA staining of the human/mouse hybrid antibodies.** (A and C) dsDNA binding curves (A) and ANA staining (C) for the four putative human L chain editors (VκO18, VκO12, VκL11, and Vλ5-1) as expressed with two mouse anti-DNA H chains (3H9 and 3H9/56R) and three human H chains (OK57, KS60, and OK13; [Table 2](#tbl2){ref-type="table"}). (B and D) dsDNA binding curves (B) and ANA staining (D) for three human L chains (Vλ5-6, VκB3, and VκA27, and for some experiments VκA17) which lack an editor signature, as expressed with the H chains used in testing the putative editor L chains. The hybrid antibodies were tested for reactivity to dsDNA by ELISA. The initial antibody concentration was 10 µg/ml, with four consecutive 1:3 dilutions for ELISA (A and B). Means of at least three independent experiments are plotted, with error bars representing the standard error. For testing of ANAs by HEp2 fluorescence (ANA, C and D), antibodies were used at 50 µg/ml. Bars, 2.0 µm. The ANA staining patterns were defined according to [@bib1]; C and D). Data are representative of three to five independent experiments.](JEM_20122340_Fig2){#fig2}

L chains veto and modify DNA binding
------------------------------------

The affinity of an antibody H chain for DNA depends mainly on the number and location of Args, as has been shown by mutagenesis; substitution of the 3H9 H-chain Arg with the germline-encoded VH amino acid glutamine abolishes DNA-binding, whereas addition of Args enhances DNA binding by 10- and 100-fold in 3H9 forward mutants 3H9/56R and 3H9/56R/76R ([@bib23]; [@bib28]; [@bib17]; [@bib3]). These anti-DNA H chains were expressed in mature B cells only when associated with editor L chains ([@bib17], [@bib18]).

To test whether the putative human editor L chains can edit 3H9 and its derivative H chain 3H9/56R, we examined the anti--double stranded DNA (dsDNA) and ANA activities of hybrid antibodies, where these H chains were expressed with each of four putative human editor L chains: VκO8/O18, VκO2/O12, VκL11, and Vλ5-1 ([Fig. 2](#fig2){ref-type="fig"}). All four L chains vetoed the 3H9 H chain binding to dsDNA, and two L chains, VκO2/O12 and Vλ5-1, decreased the affinity of 3H9/56R for DNA ([Fig. 2](#fig2){ref-type="fig"}).

Given the resemblance between the immune systems of man and mice, editors may be important in humans. Some human H chains have Args in their CDRs; hence, these H chains may have anti-DNA properties. We expressed four apparent anti-DNA human H chains with H3 Args and two mouse anti-DNA H chains 3H9 and 3H9/56R ([Table 2](#tbl2){ref-type="table"}) in combination with L chains that lack editor properties (i.e., VκA27, VκB3, and Vλ5-6) in 293 HEK cells. 11 out of 18 hybrid antibodies exhibited dsDNA or ANA activity ([Fig. 2, B and D](#fig2){ref-type="fig"}). We also cotransfected the same human H chains with the putative human editor L chains and examined the anti-dsDNA and ANA activities of the recombinant antibodies ([Fig. 2](#fig2){ref-type="fig"}). The DNA and ANA activities of human H chains OK57 and OK13 were silenced by VκO2/O12, VκO8/O18, and Vλ5-1 L chains, as were activities of H chain KS60 by VκO8/O18 and Vλ5-1L chains. H chain OK7, with one H3 Arg, exhibited neither DNA binding nor ANA activity when expressed with editor or non-editor L chains (not depicted), indicating that H3 Args are not always sufficient for DNA binding.

###### 

Expressed mouse and human H chain names and CDRs protein sequences

  Name                          VH/DH/JH                       CDR1    CDR2                            CDR3
  ----------------------------- ------------------------------ ------- ------------------------------- ---------------------------------
  **Mouse anti-DNA H chains**                                                                          
  3H9                           VMU-3.2/DSP2.13/JH3            SSWMN   **R**IYP**R**DGDINYNGKFKD       A**R**SKYSYVMDY
  56R                           VMU-3.2/DSP2.13/JH3            SSWMN   **R**IYP**R**DG**R**INYNGKFKD   A**R**SKYSYVMDY
  **Human H chains**                                                                                   
  OK57                          IGHV3-30-3/IGHD5-5(18)/IGHJ4   SYAMH   VISYDGSNKYYADSVKG               SKL**RR**TGALCGY
  OK13                          IGHV4-34IGHD/D5-5/IGHJH3       GYYWS   EINHSGS-TNYNPSLKS               **RR**A**R**GYSYGD**R**LANDAFDI
  KS60                          IGHV3-21/IGHD3-22/IGHJ3        SYSMN   SISSSSSYIYYADSVKG               AFDYD**RR**V**RR**GLDAFDI
  OK7                           IGHV3-21/IGHD3-22/IGHJ1        SYSMN   SISSSSSYIYYADSVKG               **R**ADYYDSSGYHEYFQH

L chains can modify the avidity and the specificity of anti-DNA antibodies
--------------------------------------------------------------------------

We tested the ANA activity of the expressed antibodies described above. ANA activity correlated with DNA binding for 32 out of 35 expressed antibodies in our survey ([Fig. 2](#fig2){ref-type="fig"}). The ANA staining pattern varied with L chain usage; 3H9/56R H chain expressed with Vλ5-6 exhibited a homogeneous nuclear pattern, but 3H9/56R with VκB3 showed a nucleolar pattern ([Fig. 2 D](#fig2){ref-type="fig"}). A specificity shift was previously observed with mouse antibodies; 3H9/56R H chain combined with most L chains bound dsDNA, but the 3H9/56R/Vκ38c antibody bound Sm/ribonucleoprotein (RNP; [@bib15]).

B cells expressing Vκ editor L chains have a biased H chain repertoire
----------------------------------------------------------------------

The in vitro expression experiments described above demonstrate that human editor L chains can veto anti-DNA binding of H chains. Therefore, we asked whether these L chains edit endogenous anti-DNA H chains in the human B cell repertoire. In a previous study, we showed that the mouse editor L chains are predominantly associated with endogenous H chains with H3 Args (putative anti-DNAs; [@bib12]). We hypothesize that this bias is the result of receptor editing. Here, we performed this analysis in humans; we isolated 268 single peripheral blood B cells from healthy donors and sequenced the H and L chain genes expressed in each B cell. We then compared the H chains with the editor Vκ L chains VκO8/O18, VκO2/O12, and VκL11 to those with non-editor Vκ L chains ([Table 1](#tbl1){ref-type="table"}). The VH family distribution in B cells expressing the editor L chains was similar to that of B cells expressing non-editor L chains ([Fig. 3](#fig3){ref-type="fig"}). The VH3 family was expressed by \>55% of B cells, followed by the VH4 family, which was expressed in \>20%, and the VH1 family, which was expressed by 15%, and the expression of the VH5 and VH6 families was \<5% of analyzed B cells. This distribution is the same as reported earlier ([@bib2]). Thus, the sorted population of peripheral B cells was representative of a human B cell repertoire. However, the B cells expressing editor L chains exhibited a significantly higher frequency of H chains with Args in H3 (60%) as compared with B cells expressing non-editor L chains (40%; P \< 0.005, χ^2^ test; [Fig. 3 B](#fig3){ref-type="fig"}).

![**VH repertoire and percentage of VHs with H3 Args in sorted human B cells grouped by putative editor and non-editor L chain expression**. (A) Frequency of each VH in B cells expressing potential editor (dark bars) and non-editor (light bars) Vκ L chains. (B) Percentage of H chains with H3 Args expressed with editor (dark bars) and non-editor (light bars) Vκ L chains. B cells were obtained from peripheral blood of five healthy human donors. H and L chain from the single-sorted Vκ-expressing B cells (CD20^+^Vκ^+^) were amplified from cDNA and sequenced. *n* = 72 (100%) for B cells expressing editor Vκs and *n* = 194 (100%) for B cells expressing non-editor Vκs from five healthy donors. \*, P = 0.01, χ^2^ test.](JEM_20122340_Fig3){#fig3}

Another feature of the edited antibodies of the mouse is a high frequency of distal Jκ genes ([@bib22]). We compared the frequency of different Jκ genes in editor L chains that were expressed in combination with H chains with H3 Args to that of the same L chains that were expressed with H chains without H3 Arg and found a higher frequency of distal Jκ usage in editor L chains associated with H chains which have H3 Args ([Table 3](#tbl3){ref-type="table"}; P = 0.075, χ^2^ test). When we performed the same calculations for L chains that do not have editor properties, we did not find any change in Jκ usage between L chains that were expressed with H3 Arg H chains and H chains without H3 Arg (unpublished data).

###### 

Jκ usage in L chain editors expressed with H chains which have H3 Args and H chains which lack Arg in H3

  Editor L chains       Jκ1        Jκ2        Jκ3       Jκ4        Jκ5
  --------------------- ---------- ---------- --------- ---------- ---------
  L11 (no H3 Args)      2 (67%)    1 (33%)                         
  L11 (H3 Args)         2 (50%)                         2 (50%)    
  O2/O12 (no H3 Args)   2 (11%)    10 (56%)   1 (6%)    3 (17%)    2 (11%)
  O2/O12 (H3 Args)      8 (31%)    8 (31%)    3 (12%)   5 (19%)    2 (8%)
  O8/O18 (no H3 Args)   2 (25%)    2 (25%)    1 (13%)   3 (38%)    
  O8/O18 (H3 Args)                 1 (8%)     2 (15%)   6 (46%)    4 (31%)
  Total (no H3 Args)    6 (21%)    13 (43%)   2 (7%)    6 (21%)    2 (7%)
  Total (H3 Args)       10 (23%)   9 (21%)    5 (12%)   13 (30%)   6 (14%)

Lambda editors
--------------

The mouse lambda locus includes an efficient editor, VλX, which has high sequence homology to the human Vλ5 lambda family. We isolated human Vλ5 cells using a mouse anti-VλX mAb ([Fig. 4](#fig4){ref-type="fig"}), and we sorted single B cells from the CD20^+^ VλX^+^ population ([Fig. 4](#fig4){ref-type="fig"}, right) and sequenced the L chain genes. Most of these B cells (80%) expressed L chains of the Vλ5 family.

![**VλX^+^ B cells in mouse and human.** Splenocytes from B6 WT (left) mice were stained with Phycoerythrin/Cy7 anti-CD19 and Alexa Fluor 647 anti-λX monoclonal antibodies ([@bib26]). Human peripheral blood B cells (right) were stained with Phycoerythrin/Cy7 anti-CD20 and Alexa Fluor 647 anti-λX monoclonal antibodies ([@bib26]).](JEM_20122340_Fig4){#fig4}

The expression of individual genes from the Vλ5 family in VλX^+^ sorted population was variable. Vλ5-1, the L chain in the Vλ5 family closest to VλX, is underrepresented in the human repertoire; we found only one productive rearrangement and no nonproductive ones in 226 Vλ5 cells. Given that the Vλ5 family comprises 1--2% of all B cells as identified by staining ([Fig. 4](#fig4){ref-type="fig"}), the frequency of Vλ5-1 expression is estimated to be 1 in 17,000 B cells. For Vλ5-2, we found only three productive and two nonproductive rearrangements. The frequencies of Vλ5-4 and Vλ5-6 genes are 1 in 800 and 1 in 85 B cells, respectively. These data are in agreement with the analysis of VL gene expression in a large number of healthy individuals using a L-chain microarray chip, on which neither Vλ5-1 nor Vλ5-2 were detected ([@bib27]). Vλ5-1 L chain was detected on the L-chain microarray chip analysis of B cells from SLE patients ([@bib27]). Low Vλ5-1 and Vλ5-2 expression could be explained by the stop codon at the 3′ end of these V genes. This restricts the possibility of an in-frame rearrangement to just one register. Also, Vλ5-1 is most proximal to the JC genes in the lambda locus ([@bib13]); therefore, this V gene will be deleted by most lambda rearrangements. Alternatively, Vλ5-1 might be edited because it binds proteins such as myelin basic protein (MBP: [@bib6],[@bib7]). A majority (202 out of 226) of the B cells from the CD20^+^ VλX^+^ population expressed the Vλ5-6 L chain. This L chain has high homology to the mouse editor VλX, except for the H3 region, but as we showed by in vitro expression experiments, Vλ5-6 does not silence anti-DNA or ANA activity when paired with mouse anti-DNA H chains or with human H chains with Args in H3 ([Fig. 2, B and D](#fig2){ref-type="fig"}). A comparative analysis of frequencies of H chains with H3 Args in antibodies that express Vλ5-6 to that of antibodies expressing Vκ editor L chains also indicates that Vλ5-6 belongs to the non-editor group. In antibodies expressing Vλ5-6, the percentage of H chains with H3 Args was lower (33%) than that of antibodies expressing Vκ editor L chains (60%; P \> 0.005, Chi-Square test; [Table 4](#tbl4){ref-type="table"}).

###### 

The frequency of human H chains with Arg in CDR3 in antibodies expressing Vκ editor, Vκ non-editor, and Vλ 5-6 human L chains from sorted peripheral blood

  B cell population that expresses:   Number of H chain sequences analyzed   Number of H chains with Arg in CDR3
  ----------------------------------- -------------------------------------- -------------------------------------
  Vκ editors                          72                                     43 (60%)\*
  Vκ non-editors                      194                                    77 (40%)
  Vλ 5-6                              142                                    47 (33%)

The number and percentage of H chains with Arg in CDR3 region in antibodies expressing Vκ editor, Vκ non-editor, and Vλ 5-6 L chains are shown. The CDR regions were identified according to the Kabat numbering scheme. \*, P \< 0.005, χ^2^ test.

DISCUSSION
==========

The Human L chain repertoire includes L chains that can modify DNA binding of H chain
-------------------------------------------------------------------------------------

A comparison of human and mouse L chain sequences identified human L chains that resemble the mouse editor L chains. To test whether these human L chains can function as editors to modify the DNA-binding capacity of an H chain, we expressed them in association with the mouse H chains known to bind DNA ([@bib9]). These human L chain editors reduce the affinity for DNA of mouse anti-DNA H chains. They also decrease the DNA binding of human H chains with H3 Args ([Fig. 2](#fig2){ref-type="fig"}). The degree to which DNA affinity is reduced ranges from no detectable DNA binding to intermediate levels of binding, depending on the particular L chain. The affinity range correlates with the number and location of Asps in the editor L chain; the most effective Asps are located in the CDRs, such as Asp~60~ (L2) and Asp~96~ (L3). These Asps are conserved between mouse and human editors ([Table 1](#tbl1){ref-type="table"}). The crystal structures of VλX antibodies ([@bib19]) show that Asp~60~ interacts with H3 Arg. Conversely, the position of H-chain Args can also determine the efficiency of editing. Some Args, such as the Arg~76~ in VH framework region 3, cannot be accessed by L chain; hence, antibodies that include a framework region Args in addition to CDR Args are only partially edited by any of the L chain editors.

L chain can modify the specificity of anti-DNA antibodies
---------------------------------------------------------

Certain editor L chains veto DNA binding, thereby changing the specificity to an unknown antigen. Mouse editor Vκ21D efficiently vetoes DNA binding and ANA activity of 3H9/56R H chain, but Vκ38c paired with 3H9/56R acquires new auto-specificities, including binding to Sm/RNP and to the Golgi apparatus ([@bib14]; [@bib15]). Another 3H9/56R/L chain combination, 3H9/56R/VλX, binds both DNA and MBP ([@bib5]). Here, we found that ANA staining patterns depend on human L chain usage and can shift from the nuclear homogeneous to the nucleolar pattern. Similarly, [@bib33] have shown that L chain exchange in certain antibodies changes the ANA patterns. Therefore, human L chains can modify both affinity and specificity of autoreactive antibodies.

Receptor editing in vivo
------------------------

Receptor editing has been convincingly demonstrated in mice, and here we address whether receptor editing is effectively used to regulate anti-DNA B cells in humans. In mice, we showed that endogenous H chains which contain H3 Args are preferentially associated with editor L chains ([@bib12]). Here, we compared sequences of H chains expressed with putative editor human L chains to human L chains lacking editor properties and found that antibodies expressing editor human L chains have a higher frequency of H chains with H3 Args (60%) compared with antibodies expressing non-editor L chains (40%; P \> 0.004, χ^2^ test; [Fig. 3](#fig3){ref-type="fig"}).

Because of the correlation between DNA binding and H3 Args, we infer that the observed difference in the H chain repertoire is a result of receptor editing in humans as well as in mice. Another indicator of receptor editing is a bias of JL usage to Jκ3/Jκ4/Jκ5 of the κ L chain editors ([@bib22]) and we found that the editor L chains expressed with H chains with H3 Args have a trend toward a higher frequency of Jκ3/Jκ4/Jκ5 rearrangements ([Table 3](#tbl3){ref-type="table"}).

Conservation of editors
-----------------------

The conservation of editor L chains between mouse and human is remarkable and argues for the importance of these L chains. VλX has little homology (\<33% amino acid sequence identity) to either mouse λ or κ V genes, suggesting that VλX, Vλ, and Vκ diverged at the same time ([@bib25]). Nevertheless, VλX is conserved across species ([@bib25]); mouse VλX and human Vλ5-1 are 70% identical ([@bib26]). Moreover, Vλ5-1 and VλX share unusual characteristics such as a long L3 region and a stop codon just 3′ of the V coding region. The mouse anti-VλX mAbs cross-react with Vλ5-expressing B cells, which allows us to calculate the frequency of the human Vλ5 (VλX-like) family expression in the mature B cell repertoire; this low frequency is also found for VλX in mice ([Fig. 4](#fig4){ref-type="fig"}). The Vλ5-1 and the mouse VλX also share specificity. The mouse editor VλX alone and in combination with most H chains binds MBP ([@bib6]) and it was shown that a human IgM/Vλ antibody, that is recognized by an anti-VλX mAb, is also MBP-reactive ([@bib20]).

The putative human editor VκO8/O18 shares properties with the mouse editor Vκ38c both in sequence homology and editing properties. Moreover, studies of Ig L chain amyloidosis documented that VκO8/O18 L chains form amyloidogenic proteins ([@bib4]). Mouse Vκ38c antibodies were shown to be secreted in the form of extracellular aggregates called spherons that stain with the amyloid-selective dye thioflavin T ([@bib14]). The similarities between mouse and human editors indicate that these editors may perform similar functions.

Conclusions
-----------

Our data demonstrate that the human L chain repertoire includes editor L chains as do mice and presumably other species. Our finding that human editor L chains associate with H chains which have an elevated frequency of H3 Args suggests that humans use receptor editing to regulate anti-DNA B cells. We also show here that receptor editing shapes the B cell repertoire. Editor L chains rescue expression of anti-DNA H chains, and likewise anti-DNA H chains rescue some editor L chains. Some antibodies that express editor L chains, such as mouse VH7183/VλX, are frequently used in broadly neutralizing antiviral antibodies ([@bib16]). Another antibody with the same editor L chain MW1/VλX is reactive to poly-Q repeats ([@bib19]). Therefore, editing of self-reactive antibodies is important for both protective immunity and tolerance.

MATERIALS AND METHODS
=====================

### Single B cell isolation and sorting.

Samples of peripheral blood were collected from 5 healthy donors (22--50 yr old). The use of human blood was approved by the University of Chicago, Institutional Review Board (protocol 14801B), and informed consent was obtained from all participants. Mononuclear cells were isolated from peripheral blood using Lymphocyte Separation Medium (Corning) according to the manufacturer's instructions. Purified mononuclear cells were stained with anti--human antibodies FITC-labeled anti-Igκ (BD), PE-labeled anti-Igλ (BD), PE-Cy7--labeled CD20 (BD), and Alexa Fluor 647--conjugated anti-VλX monoclonal antibody (10C5), specific for the mouse VλX gene segment (provided by P.-A. Cazenave; [@bib26]). Single cell sorting was performed as described in [@bib32] with slight modifications. Single cells were sorted on a FACSAria II (BD) into 96-well PCR plates containing 4 µl lysis solution (0.5× PBS containing 10 mM dithiothreitol and 8.4 U RNase Inhibitor \[New England Biolabs, Inc.\]); plates were immediately frozen on dry ice and stored at −80°C. Single B cells expressing Vκ genes (CD20^+^ Vκ^+^) and VλX^+^ B cells (CD20^+^ VλX^+^) were sorted separately.

### cDNA synthesis, PCR, and sequencing.

For cDNA synthesis, RNA from single cells was reverse transcribed at 37°C for 55 min with 150 ng random hexamer primer (Integrated DNA Technologies), 0.5 µl dNTP mix (10 mM each, Fermentas), 1 µl of 0.1 M dithiothreitol (Invitrogen), 0.5% (vol/vol) Nonidet P-40, 5.6 U RNase inhibitors (New England Biolabs, Inc.), and 50 U Superscript III reverse transcription (Invitrogen) in a total volume of 14 µl. Heavy and light chain genes from single cells were amplified by PCR from cDNA using two rounds of reactions with previously published nested primers ([@bib30]; 40 µl reactions included 10 pmol of each primer and 0.4 µl of JumpStart *Taq* DNA polymerase \[Sigma-Aldrich\]). Aliquots of second PCR products were purified by incubation with 10 U alkaline phosphatase, calf intestinal (CIP; New England Biolabs, Inc.), and 20 U exonuclease I (New England Biolabs, Inc.) in 1× NEB 3 buffer for 15 min at 37°C and sequenced using the reverse primers at the University of Chicago sequencing core. VH, DH, JH, VL, and JL usage was identified using IgBLAST.

### Generation of recombinant antibodies.

The recombinant antibodies were generated as described previously ([@bib30]). In brief, PCR products of particular VH, Vκ, and Vλ genes were cloned into IgG1, Igκ, or Igλ expression vectors, respectively. Several expressed Vκ (A27, L11, O8/O18, and O2/O12) and Vλ (5--6) genes were provided by the Patrick Wilson laboratory (University of Chicago, Chicago, IL). Equimolar amounts of expression vectors containing the desired IgH or IgL genes were cotransfected into the 293 cell line using the polyethylenimine, linear, mol wt--25,000 (PEI) transfection reagent (Polysciences, Inc.). The recombinant antibodies were purified from the cell supernatant 5 d after transfection using Pierce Protein A Trisacryl Resin (Thermo Fisher Scientific) and concentrated with Amicon Ultra Centrifugal Filters (Millipore) according to the manufacturer's instructions. Antibody concentrations were determined using a NanoDrop Spectraphotometer ND-1000 (NanoDrop Technologies).

### ELISA for dsDNA binding.

Antibody concentrations were adjusted to 10 µg/ml, and four consecutive 1:3 dilutions in blocking solution (1% BSA in PBS) were prepared. ELISA assays were performed as described previously ([@bib22]). Immulon 4 HBX ELISA plates (Thermo Fisher Scientific) were coated with 10 µg avidin D (Vector Laboratories) in PBS at 4°C overnight, blocked in PBS with 1% BSA at RT for 2 h, and washed with PBS with 0.05% Tween (PBS-T). Biotinylated dsDNA was bound to avidin-coated plates at 37°C for 1.5 h. Diluted antibodies were applied for 1.5 h at 37°C, plates were washed three times, and DNA--Ab complexes were detected with alkaline phosphatase--conjugated anti--human IgG (H+L) Ab (Bio-Rad Laboratories). After absorption for 90 min, plates were washed and the remaining anti-dsDNA Abs were quantified using AP substrate (Sigma-Aldrich). The OD was determined at 405 nm.

### ANA assay.

Antibody concentrations were adjusted to 50 µg/ml to test for antinuclear antigen binding using a HEp-2 ANA kit (Bion Enterprises, LTD) according to the manufacturer's instructions. Slides were examined on a DMR fluorescence microscope (Leica). Images were captured using a 63×/1.40-0.60 oil objective (Leica) and a 10×/25 ocular (Leica), with a Retiga 200R camera (Q Imaging) and Q Capture Pro (Media Cybernetics) imaging software.

### Statistical analysis.

P-values for Ig gene repertoire analysis and arginine content in H3 were calculated using the χ^2^ test.
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